Click here for a preview of the slide presentations. They can also be downloaded.

To view the Webcourse, please scroll to the bottom of the page
and click on the View/Register Now button.

PROGRAM DESCRIPTION

Despite the recent regulatory approval of a new blood-pool contrast agent for use with magnetic resonance angiography (MRA) of aorto-iliac occlusive disease, radiologists continue to use unapproved extracellular contrast agents. Blood-pool contrast agents are likely to play a greater role in medical imaging and are being evaluated for use in a variety of conditions, including assessment of tumor type in oncology patients. Wider adoption and implementation of blood-pool contrast-enhanced MRA can substantially improve patient care and clinical outcomes.

This educational program will enhance radiologists’ awareness of the latest technological advancements in the area of contrast agents for use with MRA. It will clarify issues surrounding appropriate use, and provide radiologists with a keen understanding of the clinical applications for MRA evaluation of a variety of atherosclerotic diseases and tumor types. Radiologists will also become more familiar with specific equipment set-ups to optimize imaging requirements, and will be better able to implement this important technology in their practice.

Faculty

	Neil M. Rofsky, MD (Chair) (read bio) Professor and Chairman, Radiology UT Southwestern Medical Center Dallas, TX
	James C. Carr, MD  (read bio) Associate Professor Director, Cardiovascular Imaging Department of Radiology Northwestern University Feinberg School of Medicine Chicago, IL
	Jeffrey H. Maki, MD, PhD  (read bio) Associate Professor of Radiology Director of Body MR University of Washington/Puget Sound VAHCS Seattle, WA
	Martin R. Prince, MD, PhD (read bio) Professor of Radiology, Weill Medical College of Cornell University Professor of Radiology, Columbia College of Physicians and Surgeons Chief of MRI, New York Hospital New York, NY

TARGET AUDIENCE

This program is intended for medical imaging professionals, including radiologists, radiation oncologists, medical physicists, and allied scientists.

EDUCATIONAL OBJECTIVES

This activity was designed to address the following IOM competencies: provide patient centered care and employ evidence-based practice.
At the conclusion of this activity, participants should be able to:

DISCLOSURE POLICY

This educational activity was developed in adherence with the policies and guidelines, including the Standards for Commercial Support, set forth by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of this medical education program are required to disclose any relevant financial relationships with any commercial interest. Any conflicts are identified and resolved in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Neil M. Rofsky, MD – Consultant: AMAG, Lantheus Medical Imaging
James C. Carr, MD – Investigator: Siemens
Jeffrey H. Maki, MD, PhD – Speaker: Lantheus Medical Imaging; Educational Development: Lantheus Medical Imaging; Investigator: Bracco
Martin R. Prince, MD, PhD – Patents with: Siemens, General Electric, Philips, Hitachi, Nemato, Medrad, Mallinckrodt, Bracco, Bayer Healthcare Pharmaceuticals, Epix, Lantheus Medical Imaging, Toshiba, and TopSpins

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Carole Drexel, PhD; Bradley Pine; Mira Valkova; Blair St. Amand; Laurie Frueh, MD: Nothing to Disclose

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

SYSTEM REQUIREMENTS

In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.

INSTRUCTIONS FOR PARTICIPATION

There is no fee for this activity, which was developed as a fair-balanced program in accordance with ACCME guidelines. RSNA does not allow programs developed in conjunction with their annual meeting to provide CME/CE credit to participants. As a result, no credit is offered for the completion of this educational activity.

 

This program is supported by an educational grant from

Educational Partner